GB1230890A - - Google Patents
Info
- Publication number
- GB1230890A GB1230890A GB1230890DA GB1230890A GB 1230890 A GB1230890 A GB 1230890A GB 1230890D A GB1230890D A GB 1230890DA GB 1230890 A GB1230890 A GB 1230890A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lymphoid leukosis
- erythroblastosis
- virus
- leukosis
- lymphoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 206010049466 Erythroblastosis Diseases 0.000 abstract 5
- 241000700605 Viruses Species 0.000 abstract 4
- 210000001519 tissue Anatomy 0.000 abstract 4
- 241000271566 Aves Species 0.000 abstract 3
- 239000007788 liquid Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 244000144977 poultry Species 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 210000002149 gonad Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000007918 pathogenicity Effects 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73962268A | 1968-06-25 | 1968-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1230890A true GB1230890A (enExample) | 1971-05-05 |
Family
ID=24973116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1230890D Expired GB1230890A (enExample) | 1968-06-25 | 1969-06-02 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3590128A (enExample) |
| BR (1) | BR6910100D0 (enExample) |
| CH (1) | CH506622A (enExample) |
| DE (1) | DE1931956A1 (enExample) |
| FR (1) | FR2014188B1 (enExample) |
| GB (1) | GB1230890A (enExample) |
| NL (1) | NL6909516A (enExample) |
| ZA (1) | ZA693919B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3981771A (en) * | 1973-07-19 | 1976-09-21 | Martin Sevoian | Marek's disease vaccine |
-
1968
- 1968-06-25 US US739622A patent/US3590128A/en not_active Expired - Lifetime
-
1969
- 1969-06-02 GB GB1230890D patent/GB1230890A/en not_active Expired
- 1969-06-02 ZA ZA693919A patent/ZA693919B/xx unknown
- 1969-06-20 NL NL6909516A patent/NL6909516A/xx unknown
- 1969-06-24 DE DE19691931956 patent/DE1931956A1/de active Pending
- 1969-06-24 FR FR696921164A patent/FR2014188B1/fr not_active Expired
- 1969-06-24 BR BR210100/69A patent/BR6910100D0/pt unknown
- 1969-06-25 CH CH974069A patent/CH506622A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA693919B (en) | 1971-01-27 |
| FR2014188A1 (enExample) | 1970-04-17 |
| US3590128A (en) | 1971-06-29 |
| DE1931956A1 (de) | 1970-01-15 |
| NL6909516A (enExample) | 1969-12-30 |
| BR6910100D0 (pt) | 1973-02-27 |
| FR2014188B1 (enExample) | 1973-01-12 |
| CH506622A (de) | 1971-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wiktor | Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin | |
| GB1183506A (en) | New vaccines for combating influenza and the preparation thereof | |
| GB1292803A (en) | Improvements relating to the production of antigens | |
| GB1154743A (en) | Aminoethanols | |
| BIGLER | Tetanus immunization: a ten year study | |
| GB1230890A (enExample) | ||
| DK133311C (da) | Fremgangsmade til fremstilling af en vaccine til bekempelse af marek's syge indeholdende levende ikke-svekket,celleassocieret virus | |
| GB1071922A (en) | Improvements in or relating to vaccines | |
| ES258463A1 (es) | Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis | |
| Lavrov et al. | Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine | |
| GB1462545A (en) | Feline rhinotracheitis vaccine and production thereof | |
| Seastone | The Effect of Sulfanilamide (Para-Amino-Benzenesulfonamide) on Group “C” Hemolytic Streptococcus Infections | |
| GB1187830A (en) | Pharmaceutical Compositions comprising Polynucleotides | |
| Clark Jr et al. | Effect of Actinospectacin (Trobicin) in Experimental Syphilis in the Rabbit—II: II. IN SUBCLINICAL INCUBATING SYPHILIS | |
| GB1234747A (en) | Improvements in or relating to the protection of domestic animals against pathogenic organisms | |
| Rossi et al. | Studies of Laryngotracheitis Virus in Avian Tissue Cultures: III. Enhancement of Infectivity by Diethylaminoethyl-Dextran | |
| GB1214712A (en) | Contraceptive preparations | |
| Nagano et al. | Enhancement of endotoxin-induced virus-inhibiting factor or interferon production by pretreatment of the rabbit with Newcastle disease virus | |
| SU268593A1 (enExample) | ||
| Nakamura et al. | Biological study on pulp capping. I. A clinico-pathological study on the capping effects of" Neodyne"(zinc oxide eugenol cement) upon exposed pulp due to cavity preparation by air turbine under sterile distilled water spray | |
| AT248791B (de) | Verfahren zum Schützen von Hunden vor Staupe | |
| FR2012406A1 (en) | Swine fever vaccine - freeze-dried and contg stabiliser | |
| BE768813A (fr) | Acides aminoalkanoiques substitues, leurs sels acceptables pourl'usage pharmaceutique, leur preparation et leurs utilisations therapeutiques | |
| USD210524S (en) | Burial vault | |
| Green et al. | The Effect of Separate Inoculation of Serum and Virus Upon the Protection-Test in Vaccinia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |